IP Library › Granted Patent US 7,825,149
Granted Patent B2
US 7,825,149 · App. 12/535,373 · Granted Nov 2, 2010

Substituted imidazoles

Assignee: Pfizer Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,825,149
App. No.
12/535,373
Granted
Nov 2, 2010
Kind
B2
Abstract

This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.

Claims (55)

1. A compound of formula (I):

wherein:

R 1 , R 2 , R 3 , R 4 , R 5 are each independently selected from the group consisting of hydrogen, halo, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl;

R 6 is hydrogen;

R 8 and R 9 are each independently selected from the group consisting of hydrogen and C 1-4 alkyl, but with the proviso that R 8 and R 9 are not both hydrogen;

R 11 and R 12 are each independently selected from the group consisting of hydrogen, C 1-2 alkyl, and C 1-2 alkoxy;

or a pharmaceutically, veterinary, or agriculturally acceptable salt thereof, with the proviso that the compound of Formula (I) is not 2-[(1S)-1-(2,3-dimethyl-phenyl)ethyl]-1H-imidazole.

2. A compound as claimed in claim 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 are each independently hydrogen and C 1-4 alkyl.

3. A compound as claimed in claim 1 wherein R 11 and R 12 are both hydrogen.

4. A compound as claimed in claim 1 selected from the group consisting of:

2-[1-(2-chloro-3-methyl-phenyl)ethyl]-1H-imidazole;

2-[1-(2,4-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(4-chloro-3-methyl-phenyl)ethyl]-1H-imidazole;

2-[1-(2,3-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(3,4-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chlorophenyl)-ethyl]-1H-imidazole;

2-[1-(2-chloro-4-methoxy-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-2-methoxy-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-4-methoxy-phenyl)ethyl]-1H-imidazole;

2-[1(2,5-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-4-methyl-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-2-methyl-phenyl)ethyl]-1H-imidazole;

2-[1-(2-chloro-5-methoxy-phenyl)ethyl]-1H-imidazole; and

2-[1-(2-chloro-5-methyl-phenyl)ethyl]-1H-imidazole

or a pharmaceutically, veterinarily, or agriculturally acceptable salt thereof.

5. A method of treating a parasitic infection in plants or animals by administering an effective amount of a compound of formula (I)

wherein:

R 1 , R 2 , R 3 , R 4 , R 5 are each independently selected from the group consisting of hydrogen, halo, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl;

R 6 is hydrogen;

R 8 and R 9 are each independently selected from the group consisting of hydrogen and C 1-4 alkyl, but with the proviso that R 8 and R 9 are not both hydrogen;

R 11 and R 12 are each independently selected from the group consisting of hydrogen, C 1-2 alkyl, and C 1-2 alkoxy;

or a pharmaceutically, veterinary, or agriculturally acceptable salt thereof, and when treating animals, the compound is not 2-[(1S)-1-(2,3-dimethyl-phenyl)ethyl]-1H-imidazole.

6. The method of claim 5 for treating a parasitic infection in plants or animals by administering an effective amount of a compound of Formula (I) selected from the group consisting of:

2-[1-(2-chloro-3-methylphenyl)ethyl]-1H-imidazole;

2-[1-(2,4-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(4-chloro-3-methyl-phenyl)ethyl]-1H-imidazole;

2-[1-(2,3-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(3,4-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chlorophenyl)-ethyl]-1H-imidazole;

2-[1-(2-chloro-4-methoxyphenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-2-methoxyphenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-4-methoxyphenyl)ethyl]-1H-imidazole;

2-[1-(2,5-dichloro-phenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-4-methylphenyl)ethyl]-1H-imidazole;

2-[1-(3-chloro-2-methylphenyl)ethyl]-1H-imidazole;

2-[1-(2-chloro-5-methoxyphenyl)ethyl]-1H-imidazole; and

2-[1-(2-chloro-5-methyl-phenyl)ethyl]-1H-imidazole

or a pharmaceutically, veterinarily, or agriculturally acceptable salt thereof.

7. A composition comprising a compound of Formula (I)

wherein:

R 1 , R 2 , R 3 , R 4 , R 5 are each independently selected from the group consisting of hydrogen, halo, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl;

R 6 is hydrogen;

R 8 and R 9 are each independently selected from the group consisting of hydrogen and C 1-4 alkyl, but with the proviso that R 8 and R 9 are not both hydrogen;

R 11 and R 12 are each independently selected from the group consisting of hydrogen, C 1-2 alkyl, and C 1-2 alkoxy;

or a pharmaceutically, veterinary, or agriculturally acceptable salt thereof, with the proviso that the compound of Formula (I) is not 2-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, and a pharmaceutically, veterinary, or agriculturally acceptable carrier or vehicle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2014
From: PFIZER LIMITED
To: PFIZER ANIMAL HEALTH UK 1 LIMITED
Reel/Frame 032948/0351 →
Continuity (3)
Division 1161973500 · Jan 4, 2007
Provisional Application 6076076500 · Jan 19, 2006
Related Publication 20090312326A1 · Dec 17, 2009